|
|
||||||||
From the Departments of Psychiatry (Dr. Yaffe), Neurology (Dr. Yaffe), Epidemiology (Dr. Yaffe), and Geriatrics (K. Lindquist) and Prevention Sciences Group (Dr. Yaffe, S. Rubin), University of California, San Francisco; Sticht Center on Aging (Drs. Penninx and Pahor), Wake Forest University School of Medicine, WinstonSalem, NC; Intramural Research Program (Dr. Simonsick), National Institute on Aging, and Laboratory of Epidemiology, Demography, and Biometry (Drs. Launer and Harris), National Institute on Aging, Bethesda, MD; Department of Preventive Medicine (Dr. Kritchevsky), University of Tennessee at Memphis; and Department of Epidemiology (Dr. Kuller), Graduate School of Public Health, University of Pittsburgh School of Medicine, PA.
Address correspondence and reprint requests to Dr. K. Yaffe, University of California, San Francisco, 4150 Clement St., Box 111G, San Francisco, CA 94121; e-mail: kyaffe{at}itsa.ucsf.edu
Background: Several lines of evidence suggest that inflammatory mechanisms contribute to AD.
Objective: To examine whether several markers of inflammation are associated with cognitive decline in African-American and white well-functioning elders.
Methods: The authors studied 3,031 African-American and white men and women (mean age 74 years) enrolled in the Health, Aging, and Body Composition Study. Serum levels of interleukin-6 (IL-6) and C-reactive protein (CRP) and plasma levels of tumor necrosis factor-
(TNF
) were measured at baseline; cognition was assessed with the Modified Mini-Mental State Examination (3MS) at baseline and at follow-up. Cognitive decline was defined as a decline of >5 points.
Results: In age-adjusted analyses, participants in the highest tertile of IL-6 or CRP performed nearly 2 points lower (worse) on baseline and follow-up 3MS (p < 0.001 for all) and declined by almost 1 point over the >2 years (p = 0.01 for IL-6 and p = 0.04 for CRP) compared with those in the lowest tertile. After multivariate adjustment, 3MS scores among participants in the highest tertile of IL-6 and CRP were similar at baseline but remained significantly lower at follow-up (p
0.05 for both). Those in the highest inflammatory marker tertile were also more likely to have cognitive decline compared with the lowest tertile for IL-6 (26 vs 20%; age-adjusted odds ratio [OR] = 1.34; 95% CI 1.06 to 1.69) and for CRP (24 vs 19%; OR = 1.41; 95% CI 1.10 to 1.79) but not for TNF
(23 vs 21%; OR = 1.12; 95% CI 0.88 to 1.43). There was no significant interaction between race and inflammatory marker or between nonsteroidal anti-inflammatory drug use and inflammatory marker on cognition.
Conclusions: Serum markers of inflammation, especially IL-6 and CRP, are prospectively associated with cognitive decline in well-functioning elders. These findings support the hypothesis that inflammation contributes to cognitive decline in the elderly.
This article has been cited by other articles:
![]() |
M. A. Beydoun, A. Lhotsky, Y. Wang, G. D. Forno, Y. An, E. J. Metter, L. Ferrucci, R. O'Brien, and A. B. Zonderman Association of Adiposity Status and Changes in Early to Mid-Adulthood With Incidence of Alzheimer's Disease Am. J. Epidemiol., November 15, 2008; 168(10): 1179 - 1189. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. K. Pedersen and M. A. Febbraio Muscle as an Endocrine Organ: Focus on Muscle-Derived Interleukin-6 Physiol Rev, October 1, 2008; 88(4): 1379 - 1406. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Whitmer, D. R. Gustafson, E. Barrett-Connor, M. N. Haan, E. P. Gunderson, and K. Yaffe Central obesity and increased risk of dementia more than three decades later Neurology, September 30, 2008; 71(14): 1057 - 1064. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Dickinson and P. D. Harvey Systemic Hypotheses for Generalized Cognitive Deficits in Schizophrenia: A New Take on An Old Problem Schizophr Bull, August 9, 2008; (2008) sbn097v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Locascio, H. Fukumoto, L. Yap, T. Bottiglieri, J. H. Growdon, B. T. Hyman, and M. C. Irizarry Plasma Amyloid {beta}-Protein and C-reactive Protein in Relation to the Rate of Progression of Alzheimer Disease Arch Neurol, June 1, 2008; 65(6): 776 - 785. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. H. Mizrahi, T. Blumstein, M. Arad, and A. Adunsky Serum Albumin Levels Predict Cognitive Impairment in Elderly Hip Fracture Patients American Journal of Alzheimer's Disease and Other Dementias, March 1, 2008; 23(1): 85 - 90. [Abstract] [PDF] |
||||
![]() |
M. T. Sturman, C. F. M. de Leon, J. L. Bienias, M. C. Morris, R. S. Wilson, and D. A. Evans Body mass index and cognitive decline in a biracial community population Neurology, January 29, 2008; 70(5): 360 - 367. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E. Alley, E. M. Crimmins, A. Karlamangla, P. Hu, and T. E. Seeman Inflammation and Rate of Cognitive Change in High-Functioning Older Adults J. Gerontol. A Biol. Sci. Med. Sci., January 1, 2008; 63(1): 50 - 55. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Wu, B. L. Plassman, J. Liang, and L. Wei Cognitive Function and Dental Care Utilization Among Community-Dwelling Older Adults Am J Public Health, December 1, 2007; 97(12): 2216 - 2221. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Szwast, H. C. Hendrie, K. A. Lane, S. Gao, S. E. Taylor, F. Unverzagt, J. Murrell, M. Deeg, A. Ogunniyi, M. R. Farlow, et al. Association of statin use with cognitive decline in elderly African Americans Neurology, November 6, 2007; 69(19): 1873 - 1880. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G. Dik, C. Jonker, H. C. Comijs, D. J.H. Deeg, A. Kok, K. Yaffe, and B. W. Penninx Contribution of Metabolic Syndrome Components to Cognition in Older Individuals Diabetes Care, October 1, 2007; 30(10): 2655 - 2660. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Komulainen, T. A. Lakka, M. Kivipelto, M. Hassinen, I. M. Penttila, E.-L. Helkala, H. Gylling, A. Nissinen, and R. Rauramaa Serum high sensitivity C-reactive protein and cognitive function in elderly women Age Ageing, July 1, 2007; 36(4): 443 - 448. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. S. Tan, A. S. Beiser, R. S. Vasan, R. Roubenoff, C. A. Dinarello, T. B. Harris, E. J. Benjamin, R. Au, D. P. Kiel, P. A. Wolf, et al. Inflammatory markers and the risk of Alzheimer disease: The Framingham Study Neurology, May 29, 2007; 68(22): 1902 - 1908. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Mathew, M. V. Podgoreanu, H. P. Grocott, W. D. White, R. W. Morris, M. Stafford-Smith, G. B. Mackensen, C. S. Rinder, J. A. Blumenthal, D. A. Schwinn, et al. Genetic Variants in P-Selectin and C-Reactive Protein Influence Susceptibility to Cognitive Decline After Cardiac Surgery J. Am. Coll. Cardiol., May 15, 2007; 49(19): 1934 - 1942. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. M. van Gelder, M. Tijhuis, S. Kalmijn, and D. Kromhout Fish consumption, n-3 fatty acids, and subsequent 5-y cognitive decline in elderly men: the Zutphen Elderly Study Am. J. Clinical Nutrition, April 1, 2007; 85(4): 1142 - 1147. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. Starkweather The Effects of Exercise on Perceived Stress and IL-6 Levels Among Older Adults Biol Res Nurs, January 1, 2007; 8(3): 186 - 194. [Abstract] [PDF] |
||||
![]() |
A. S. Buchman, J. A. Schneider, R. S. Wilson, J. L. Bienias, and D. A. Bennett Body mass index in older persons is associated with Alzheimer disease pathology Neurology, December 12, 2006; 67(11): 1949 - 1954. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Marsland, K. L. Petersen, R. Sathanoori, M. F. Muldoon, S. A. Neumann, C. Ryan, J. D. Flory, and S. B. Manuck Interleukin-6 Covaries Inversely With Cognitive Performance Among Middle-Aged Community Volunteers Psychosom Med, November 1, 2006; 68(6): 895 - 903. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kurella, D. L. Mapes, F. K. Port, and G. M. Chertow Correlates and outcomes of dementia among dialysis patients: the Dialysis Outcomes and Practice Patterns Study Nephrol. Dial. Transplant., September 1, 2006; 21(9): 2543 - 2548. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Dziedzic Systemic inflammatory markers and risk of dementia. American Journal of Alzheimer's Disease and Other Dementias, August 1, 2006; 21(4): 258 - 262. [Abstract] [PDF] |
||||
![]() |
C. W. Hogue Jr, T. Hershey, D. Dixon, R. Fucetola, A. Nassief, K. E. Freedland, B. Thomas, and K. Schechtman Preexisting cognitive impairment in women before cardiac surgery and its relationship with C-reactive protein concentrations. Anesth. Analg., June 1, 2006; 102(6): 1602 - 1608. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Koster, H. Bosma, B. W. J. H. Penninx, A. B. Newman, T. B. Harris, J. Th. M. van Eijk, G. I. J. M. Kempen, E. M. Simonsick, K. C. Johnson, R. N. Rooks, et al. Association of inflammatory markers with socioeconomic status. J. Gerontol. A Biol. Sci. Med. Sci., March 1, 2006; 61(3): 284 - 290. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Bursi, W. A. Rocca, J. M. Killian, S. A. Weston, D. S. Knopman, S. J. Jacobsen, and V. L. Roger Heart Disease and Dementia: A Population-based Study Am. J. Epidemiol., January 15, 2006; 163(2): 135 - 141. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Mangiafico, F. Sarnataro, M. Mangiafico, and C. E. Fiore Impaired cognitive performance in asymptomatic peripheral arterial disease: relation to C-reactive protein and D-dimer levels Age Ageing, January 1, 2006; 35(1): 60 - 65. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Bruunsgaard Physical activity and modulation of systemic low-level inflammation J. Leukoc. Biol., October 1, 2005; 78(4): 819 - 835. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Ravaglia, P. Forti, F. Maioli, N. Brunetti, M. Martelli, L. Servadei, L. Bastagli, M. Bianchin, and E. Mariani Serum C-Reactive Protein and Cognitive Function in Healthy Elderly Italian Community Dwellers J. Gerontol. A Biol. Sci. Med. Sci., August 1, 2005; 60(8): 1017 - 1021. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kurella, G. M. Chertow, L. F. Fried, S. R. Cummings, T. Harris, E. Simonsick, S. Satterfield, H. Ayonayon, and K. Yaffe Chronic Kidney Disease and Cognitive Impairment in the Elderly: The Health, Aging, and Body Composition Study J. Am. Soc. Nephrol., July 1, 2005; 16(7): 2127 - 2133. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A Whitmer, E. P Gunderson, E. Barrett-Connor, C. P Quesenberry Jr, and K. Yaffe Obesity in middle age and future risk of dementia: a 27 year longitudinal population based study BMJ, June 11, 2005; 330(7504): 1360. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Di Napoli, M. Schwaninger, R. Cappelli, E. Ceccarelli, G. Di Gianfilippo, C. Donati, H. C.A. Emsley, S. Forconi, S. J. Hopkins, L. Masotti, et al. Evaluation of C-Reactive Protein Measurement for Assessing the Risk and Prognosis in Ischemic Stroke: A Statement for Health Care Professionals From the CRP Pooling Project Members Stroke, June 1, 2005; 36(6): 1316 - 1329. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. B. Kritchevsky, M. Cesari, and M. Pahor Inflammatory markers and cardiovascular health in older adults Cardiovasc Res, May 1, 2005; 66(2): 265 - 275. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. S. Schmidt, D. J. Libon, F. Pezzetta, L. Mascitelli, G. Zuccala, E. Marzetti, R. Bernabei, M. J. Stampfer, J. H. Kang, and F. Grodstein Alcohol and Cognitive Function in Older Women N. Engl. J. Med., April 28, 2005; 352(17): 1817 - 1819. [Full Text] [PDF] |
||||
![]() |
M. G. Dik, C. Jonker, C. E. Hack, J. H. Smit, H. C. Comijs, and P. Eikelenboom Serum inflammatory proteins and cognitive decline in older persons Neurology, April 26, 2005; 64(8): 1371 - 1377. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. O'Connor, A. Satpathy, M. E. Hartman, E. M. Horvath, K. W. Kelley, R. Dantzer, R. W. Johnson, and G. G. Freund IL-1{beta}-Mediated Innate Immunity Is Amplified in the db/db Mouse Model of Type 2 Diabetes J. Immunol., April 15, 2005; 174(8): 4991 - 4997. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Yaffe, A. Kanaya, K. Lindquist, E. M. Simonsick, T. Harris, R. I. Shorr, F. A. Tylavsky, and A. B. Newman The Metabolic Syndrome, Inflammation, and Risk of Cognitive Decline JAMA, November 10, 2004; 292(18): 2237 - 2242. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Engelhart, M. I. Geerlings, J. Meijer, A. Kiliaan, A. Ruitenberg, J. C. van Swieten, T. Stijnen, A. Hofman, J. C. M. Witteman, and M. M. B. Breteler Inflammatory Proteins in Plasma and the Risk of Dementia: The Rotterdam Study Arch Neurol, May 1, 2004; 61(5): 668 - 672. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kalmijn, M. P.J. van Boxtel, M. Ocke, W. M.M. Verschuren, D. Kromhout, and L. J. Launer Dietary intake of fatty acids and fish in relation to cognitive performance at middle age Neurology, January 27, 2004; 62(2): 275 - 280. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |